Targeting apoptosis in cancer therapy
- PMID: 32203277
- PMCID: PMC8211386
- DOI: 10.1038/s41571-020-0341-y
Targeting apoptosis in cancer therapy
Abstract
For over three decades, a mainstay and goal of clinical oncology has been the development of therapies promoting the effective elimination of cancer cells by apoptosis. This programmed cell death process is mediated by several signalling pathways (referred to as intrinsic and extrinsic) triggered by multiple factors, including cellular stress, DNA damage and immune surveillance. The interaction of apoptosis pathways with other signalling mechanisms can also affect cell death. The clinical translation of effective pro-apoptotic agents involves drug discovery studies (addressing the bioavailability, stability, tumour penetration, toxicity profile in non-malignant tissues, drug interactions and off-target effects) as well as an understanding of tumour biology (including heterogeneity and evolution of resistant clones). While tumour cell death can result in response to therapy, the selection, growth and dissemination of resistant cells can ultimately be fatal. In this Review, we present the main apoptosis pathways and other signalling pathways that interact with them, and discuss actionable molecular targets, therapeutic agents in clinical translation and known mechanisms of resistance to these agents.
Figures
Similar articles
-
Splicing DNA Damage Adaptations for the Management of Cancer Cells.Curr Gene Ther. 2024;24(2):135-146. doi: 10.2174/0115665232258528231018113410. Curr Gene Ther. 2024. PMID: 38282448 Review.
-
Broad targeting of resistance to apoptosis in cancer.Semin Cancer Biol. 2015 Dec;35 Suppl(0):S78-S103. doi: 10.1016/j.semcancer.2015.03.001. Epub 2015 Apr 28. Semin Cancer Biol. 2015. PMID: 25936818 Free PMC article. Review.
-
The molecular control of DNA damage-induced cell death.Apoptosis. 2000 Dec;5(6):491-507. doi: 10.1023/a:1009617727938. Apoptosis. 2000. PMID: 11303908 Review.
-
Splicing DNA-damage responses to tumour cell death.Biochim Biophys Acta. 2004 Dec 10;1705(1):3-15. doi: 10.1016/j.bbcan.2004.09.001. Biochim Biophys Acta. 2004. PMID: 15585169 Review.
-
Cancer and Apoptosis.Methods Mol Biol. 2022;2543:191-210. doi: 10.1007/978-1-0716-2553-8_16. Methods Mol Biol. 2022. PMID: 36087269
Cited by
-
Necroptosis, pyroptosis and apoptosis: an intricate game of cell death.Cell Mol Immunol. 2021 May;18(5):1106-1121. doi: 10.1038/s41423-020-00630-3. Epub 2021 Mar 30. Cell Mol Immunol. 2021. PMID: 33785842 Free PMC article. Review.
-
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins.Leukemia. 2024 Dec;38(12):2561-2572. doi: 10.1038/s41375-024-02405-5. Epub 2024 Sep 17. Leukemia. 2024. PMID: 39300221 Free PMC article.
-
The Hallmarks of Flavonoids in Cancer.Molecules. 2021 Apr 2;26(7):2029. doi: 10.3390/molecules26072029. Molecules. 2021. PMID: 33918290 Free PMC article. Review.
-
Lutetium texaphyrin: A photocatalyst that triggers pyroptosis via biomolecular photoredox catalysis.Proc Natl Acad Sci U S A. 2024 Feb 27;121(9):e2314620121. doi: 10.1073/pnas.2314620121. Epub 2024 Feb 21. Proc Natl Acad Sci U S A. 2024. PMID: 38381784 Free PMC article.
-
A novel bakuchiol aminoguanidine derivative induces apoptosis in human triple-negative breast cancer cells.Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Aug 25;53(4):509-518. doi: 10.3724/zdxbyxb-2024-0070. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39183056 Free PMC article. Chinese, English.
References
-
- Ellis HM & Horvitz HR Genetic control of programmed cell death in the nematode C. elegans. Cell 44, 817–829 (1986). - PubMed
-
- Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE & Poirier GG Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53, 3976–3985 (1993). - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources